OpenLegislation

Paragraph 34A Taking effect of decisions relating to business consolidationsF1

(1)

This paragraph applies as regards a consolidation application that is granted, in relation to the person who is—

(a)

P1 for the purposes of regulation 26A (P1), if regulation 26A(3) applied to that application; or

(b)

P2 for the purposes of regulation 26A (P2), if regulation 26A(4) applied to that application.

(2)

F2NHS England may only change a pharmaceutical list to give effect to that decision if P1 or P2 gives NHS England a valid notice of consolidation, in the correct form, informing NHS England of the date on which the consolidation is to take effect in the next 14 days.

(3)

A notice of consolidation under this paragraph is in the correct form if it—

(a)

includes the information required under paragraph 29A; and

(b)

is in the same format as the version of the notice sent by NHS England with the notice of decision under paragraph 28.

(4)

A notice of consolidation is invalid unless it is sent to NHS England within—

(a)

6 months of the date on which the applicant was sent the notice of NHS England’s decision under paragraph 28 granting the application;

(b)

such longer period—

(i)

not exceeding a further 3 months as NHS England may allow, or

(ii)

if—

(aa)

the grant is appealed by a person with third party appeal rights, or

(bb)

P1 or P2 appeals successfully against a decision not to allow a longer period under paragraph (i),

as the Secretary of State may allow when the appeal is determined,

(5)

A notice of consolidation ceases to have effect if the Secretary of State receives a valid notice of appeal from a person with third party appeal rights relating to the grant to which the notice of consolidation relates.

(6)

Once, having regard to sub-paragraph (4), a valid notice of consolidation can no longer be sent in relation to the grant of a consolidation application, the grant of that application lapses.

Annotations

Textual amendments

F1

Sch. 2 para. 34A inserted (5.12.2016) by The National Health Service (Pharmaceutical Services, Charges and Prescribing) (Amendment) Regulations 2016 (S.I. 2016/1077), regs. 1(1), 18

F2

Words in Regulations substituted (6.11.2023) by The Health and Care Act 2022 (Further Consequential Amendments) (No. 2) Regulations 2023 (S.I. 2023/1071), reg. 1(1), Sch. para. 1